Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina.
We have reported in the accompanying paper that the BFRF1 protein of Epstein-Barr virus (EBV) is important for efficient primary viral envelopment and egress (A. Farina, R. Feederle, S. Raffa, R. Gonnella, R. Santarelli, L. Frati, A. Angeloni, M. R. Torrisi, A. Faggioni, and H.-J. Delecluse, J. Virol. 79:3703-3712). Here we describe the characterization of the product of the EBV BFLF2 gene, which belongs to a family of conserved herpesviral genes which include the UL31 genes of herpes simplex virus and of pseudorabies virus and whose products are known to interact with UL34, the positional homolog of BFRF1. BFLF2 is an early transcript and is expressed in a variety of cell lines upon EBV lytic cycle activation. Western blotting of purified virion preparations showed that BFLF2 is a component of intracellular virions but is absent from mature extracellular virions. Coimmunoprecipitation experiments indicated that BFLF2 interacts with BFRF1, which was confirmed by immunofluorescence confocal microscopy showing that the two proteins colocalize on the nuclear membrane not only upon cotransfection in epithelial cells but also during viral replication. In cells carrying an EBV mutant with the BFRF1 gene deleted (293-BFRF1-KO cells) BFLF2 expression was low, and it was restored to wild-type levels upon treatment of the cells with the proteasome inhibitor MG132. Furthermore, recomplementing the 293-BFRF1-KO cells by BFRF1 transfection restored BFLF2 expression to the wild-type level. In addition, when expressed alone BFLF2 was localized diffusely inside the nucleus, whereas in the presence of BFRF1 the two proteins colocalized at the nuclear rim. Finally, 293 epithelial cells transfected with either protein or cotransfected were analyzed by electron microscopy to investigate potential alterations in the morphology of the nuclear membrane. The ultrastructural analysis revealed that (i) BFRF1 caused duplications of the nuclear membrane, similar to those reported to occur during the course of herpesviral replication, and (ii) while BFLF2 alone did not cause any apparent alteration, coexpression of the two proteins dramatically induced profound convolutions of the duplicated nuclear membrane. Both biochemical and morphological analysis showed association of the BFRF1-BFLF2 complex with a component of the nuclear lamina, lamin B. Taken together, these results and those of the accompanying paper (Farina et al., J. Virol. 79:3703-3712) indicate an important role of BFRF1 and BFLF2 in the early steps of EBV maturation at the nuclear membrane.
Gonnella
Roberta
R
Istituto Pasteur Fondazione Cenci-Bolognetti, Dipartimento di Medicina Sperimentale e Patologia, Università di Roma La Sapienza, Rome, Italy.
Farina
Antonella
A
Santarelli
Roberta
R
Raffa
Salvatore
S
Feederle
Regina
R
Bei
Roberto
R
Granato
Marisa
M
Modesti
Andrea
A
Frati
Luigi
L
Delecluse
Henri-Jacques
HJ
Torrisi
Maria Rosaria
MR
Angeloni
Antonio
A
Faggioni
Alberto
A
D015153:Blotting, Western; D002460:Cell Line; D015853:Cysteine Proteinase Inhibitors; D003713:Dendritic Cells; D004847:Epithelial Cells / Q000821:virology; D017353:Gene Deletion; D005816:Genetic Complementation Test; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000502:physiology*; D006801:Humans; D047468:Immunoprecipitation; D034921:Lamin Type B / Q000378:metabolism*; D007976:Leupeptins / Q000494:pharmacology; D008565:Membrane Proteins / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D018613:Microscopy, Confocal; D008856:Microscopy, Fluorescence; D009685:Nuclear Envelope / Q000648:ultrastructure / Q000821:virology; D034881:Nuclear Lamina / Q000378:metabolism*; D016366:Open Reading Frames; D010750:Phosphoproteins / Q000032:analysis / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D011485:Protein Binding; D011994:Recombinant Proteins; D014764:Viral Proteins / Q000032:analysis / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D014771:Virion / Q000737:chemistry; D014779:Virus Replication
C406064:BFRF1 protein, Human herpesvirus 4; D015853:Cysteine Proteinase Inhibitors; D034921:Lamin Type B; D007976:Leupeptins; D008565:Membrane Proteins; D010750:Phosphoproteins; D011994:Recombinant Proteins; D014764:Viral Proteins; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Arch Virol. 1999;144(10):1923-35
10550666
J Virol. 2002 Feb;76(3):998-1003
11773375
J Mol Biol. 1999 Dec 17;294(5):1351-62
10600390
Virology. 1999 May 10;257(2):460-71
10329556
Nat Rev Mol Cell Biol. 2004 Jan;5(1):65-9
14663490
J Cell Biol. 1997 Mar 10;136(5):1007-21
9060466
J Gen Virol. 2000 Oct;81(Pt 10):2397-405
10993927
Virology. 1985 Nov;147(1):99-109
2998075
J Virol. 2004 Jan;78(1):399-412
14671121
J Biol Chem. 2002 May 24;277(21):18827-39
11901153
J Virol. 1993 Nov;67(11):6348-56
7692079
J Virol. 1998 Dec;72(12):9738-46
9811708
Curr Opin Cell Biol. 2003 Jun;15(3):338-44
12787777
Curr Biol. 2003 Dec 16;13(24):R970-2
14680657
J Virol. 2004 Jun;78(11):5591-600
15140956
Int J Oncol. 1996 Jun;8(6):1127-35
21544473
J Virol. 2000 Apr;74(7):3235-44
10708440
Nature. 2003 Aug 7;424(6949):689-94
12894213
J Virol. 2002 Sep;76(17):8939-52
12163613
Cancer Res. 1985 Nov;45(11 Pt 2):5769-80
2413997
Proc Natl Acad Sci U S A. 1973 Jan;70(1):190-4
4346033
J Virol. 2002 Jan;76(1):364-78
11739701
J Biol Chem. 1993 Apr 5;268(10):7545-52
8463284
Lancet. 1964 Feb 1;1(7327):238-40
14086209
J Virol. 1967 Oct;1(5):1045-51
4912237
Virology. 2002 Sep 1;300(2):189-204
12350350
J Virol. 2004 Jun;78(11):5564-75
15140953
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50
9653172
J Virol. 2001 Sep;75(18):8803-17
11507225
Nature. 1984 Jul 19-25;310(5974):207-11
6087149
J Virol. 2000 Nov;74(21):10063-73
11024135
J Virol. 2001 Sep;75(18):8818-30
11507226
J Med Virol. 2004 Jan;72(1):102-11
14635017
J Gen Virol. 2002 May;83(Pt 5):1005-12
11961254
Biotechnol Appl Biochem. 1988 Feb;10(1):6-12
2841949
J Virol. 2000 Jan;74(1):117-29
10590098
Int J Cancer. 1977 Jan;19(1):27-33
188769
Science. 2002 Aug 2;297(5582):854-7
12161659
Virology. 2004 Mar 1;320(1):99-106
15003866
J Virol. 2000 Feb;74(3):1355-63
10627546
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11002-7
11005871
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7552-6
3313397
J Virol. 1989 Feb;63(2):828-32
2536106
J Virol. 2000 Apr;74(7):3093-104
10708424
J Virol. 2005 Mar;79(6):3703-12
15731264
Annu Rev Cell Dev Biol. 2000;16:627-51
11031249
J Gen Virol. 1977 Jul;36(1):59-74
886304
J Gen Virol. 2001 Jun;82(Pt 6):1423-8
11369887
J Virol. 2002 Feb;76(4):1537-47
11799148